VAL-083
CAS No. 23261-20-3
VAL-083 ( Dianhydrogalactitol; Dianhydrodulcitol )
Catalog No. M24063 CAS No. 23261-20-3
VAL-083 is an alkylating compound that creates N7 methylation on DNA. It also has antitumor activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 107 | In Stock |
|
5MG | 164 | In Stock |
|
10MG | 222 | In Stock |
|
25MG | 374 | In Stock |
|
50MG | 555 | In Stock |
|
100MG | 790 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameVAL-083
-
NoteResearch use only, not for human use.
-
Brief DescriptionVAL-083 is an alkylating compound that creates N7 methylation on DNA. It also has antitumor activity.
-
DescriptionVAL-083 is an alkylating compound that creates N7 methylation on DNA. It also has antitumor activity.
-
SynonymsDianhydrogalactitol; Dianhydrodulcitol
-
PathwayCell Cycle/DNA Damage
-
TargetDNA/RNA Synthesis
-
RecptorDNA Alkylator
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number23261-20-3
-
Formula Weight146.1
-
Molecular FormulaC6H10O4
-
Purity>98% (HPLC)
-
SolubilityDMF :90 mg/mL (615.85 mM);H2O:40 mg/mL (273.71 mM; Need ultrasonic)
-
SMILESO[C@H]([C@H](O)[C@@]1([H])OC1)[C@@]2([H])CO2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Kaiji Hu, et al. Abstract 811: VAL083, a novel N7 alkylating agent, surpasses NSC 362856 activity and inhibits cancer stem cells providing a new potential treatment option for glioblastoma multiforme. Cancer Research. 2012 Mar 31-Apr 4.
molnova catalog
related products
-
2-Fluoroadenine
2-Fluoroadenine has toxicity in nonproliferating and proliferating tumor cells. 2-Fluoroadenine can be used for anticancer studies.
-
SCR7
SCR7 is a specific inhibitor of nonhomologous end-joining (NHEJ).
-
T863
T-863(DGAT-1 inhibitor) is an orally active, selective and potent DGAT1 (Acyl-CoA:diacylglycerol acyltransferase 1) inhibitor that interacts with the acyl-CoA binding site of DGAT1, and inhibits triacylglycerol synthesis in cells.